Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $1.1 million.

  • Cryo Cell International's Cash from Investing Activities rose 26595.49% to $1.1 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.8 million, marking a year-over-year increase of 6863.34%. This contributed to the annual value of -$4.9 million for FY2024, which is 4012.22% up from last year.
  • Per Cryo Cell International's latest filing, its Cash from Investing Activities stood at $1.1 million for Q3 2025, which was up 26595.49% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Cash from Investing Activities peaked at $1.9 million during Q4 2022, and registered a low of -$11.2 million during Q3 2022.
  • Its 5-year average for Cash from Investing Activities is -$1.9 million, with a median of -$1.2 million in 2023.
  • Per our database at Business Quant, Cryo Cell International's Cash from Investing Activities tumbled by 1137876.67% in 2021 and then surged by 75840.08% in 2022.
  • Quarter analysis of 5 years shows Cryo Cell International's Cash from Investing Activities stood at -$290943.0 in 2021, then soared by 758.4% to $1.9 million in 2022, then tumbled by 203.45% to -$2.0 million in 2023, then skyrocketed by 43.7% to -$1.1 million in 2024, then soared by 199.01% to $1.1 million in 2025.
  • Its Cash from Investing Activities was $1.1 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$287484.0 in Q1 2025.